MP68-09 OVERCOMING PROSTATE CANCER THERAPEUTIC RESISTANCE BY MODULATING MITOCHONDRIA-MEDIATED CELL METABOLISM AND DEATH SIGNALING
Ji Hyo Lyu(Cedars-Sinai Medical Center), Leland W. K. Chung(Cedars-Sinai Medical Center), Chengfei Liu, Allen C. Gao(UC Davis Comprehensive Cancer Center), Sungyong You(Cedars-Sinai Medical Center), Yi Zhang(Tianjin Medical University General Hospital), Gina Chia‐Yi Chu(Multimeric Biotherapeutics (United States)), Haiyen E. Zhau(Cedars-Sinai Medical Center), Stefan Mrđenović(Cedars-Sinai Medical Center)
Cited by 0
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k